IPO - COMPASS Pathways plc

Form Type: 424B5

Filing Date: 2025-01-10

Corporate Action: Ipo

Type: New

Accession Number: 000162828025001142

Filing Summary: COMPASS Pathways plc is offering 24,014,728 American Depositary Shares (ADSs), representing 24,014,728 ordinary shares, along with pre-funded warrants to purchase up to 11,044,720 ADSs. Additionally, warrants are being offered to purchase up to 35,059,448 ADSs. The offering price for each ADS is set at $4.2750, while pre-funded warrants will be sold at $4.2649. The ADS warrants are exercisable at an exercise price of $5.7960. The funds raised from this offering are intended for financing ongoing Phase 3 clinical trials for treatment-resistant depression (TRD) and general corporate purposes. The company has previously attained Breakthrough Therapy designation from the FDA for its product COMP360, aimed specifically at treatment-resistant depression. As of January 8, 2025, the last reported sale price for the ADSs was $4.14. The underwriters, including TD Cowen and Cantor, are expected to deliver the securities on January 13, 2025. There are significant risks associated with this investment, including the potential for substantial dilution and a lack of trading market for the offered warrants.

Document Link: View Document